Remarkably, CD11b+CD16+ LDNs resulted the most represented subpopulation of CD66b+CD33dimHLA-DR− cells even considering patients affected by HL, indolent and aggressive B-cell NHL lymphomas separately (data not shown). This evidence concerns the gene CEACAM8 and B-cell non-Hodgkin lymphoma.